134 related articles for article (PubMed ID: 37791546)
1. Impact of statin on renal cell carcinoma patients undergoing nephrectomy. Does it affect cancer progression and improves survival? A Systematic Review and Meta-Analysis.
Adli G; Yogiswara N; Gde Tirta Yoga Yatindra IB; Putra RM; Djatisoesanto W
Arch Ital Urol Androl; 2023 Oct; 95(3):11672. PubMed ID: 37791546
[TBL] [Abstract][Full Text] [Related]
2. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK; Boorjian SA
Urol Oncol; 2015 Sep; 33(9):388.e11-8. PubMed ID: 25700974
[TBL] [Abstract][Full Text] [Related]
3. Statin utilization improves oncologic and survival outcomes in patients with dyslipidemia and surgically treated renal cell carcinoma.
Berquist SW; Lee HJ; Hamilton Z; Bagrodia A; Hassan AE; Beksaç AT; Dufour CA; Wang S; Mehrazin R; Patterson A; Derweesh IH
Minerva Urol Nefrol; 2017 Oct; 69(5):501-508. PubMed ID: 28376607
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
Shim SR; Kim SJ; Kim SI; Cho DS
World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
[TBL] [Abstract][Full Text] [Related]
5. The association between statin medication and progression after surgery for localized renal cell carcinoma.
Hamilton RJ; Morilla D; Cabrera F; Leapman M; Chen LY; Bernstein M; Hakimi AA; Reuter VE; Russo P
J Urol; 2014 Apr; 191(4):914-9. PubMed ID: 24291547
[TBL] [Abstract][Full Text] [Related]
6. Assessment of concomitant non-oncologic medication in patients with surgically treated renal cell carcinoma: impact on prognosis, cell-cycle progression and proliferation.
Neumann E; Klaiber P; Freitag K; Schwab M; Schaeffeler E; Hennenlotter J; Fend F; Kruck S; Scharpf M; Stenzl A; Bedke J; Rausch S
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1835-1843. PubMed ID: 31006846
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oncologic outcomes between partial and radical nephrectomy for localized renal cell carcinoma: A systematic review and meta-analysis.
Gu L; Ma X; Li H; Chen L; Xie Y; Li X; Gao Y; Zhang Y; Zhang X
Surg Oncol; 2016 Dec; 25(4):385-393. PubMed ID: 27916170
[TBL] [Abstract][Full Text] [Related]
9. Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic.
Chan VW; Tan WS; Leow JJ; Tan WP; Ong WLK; Chiu PK; Gurung P; Pirola GM; Orecchia L; Liew MPC; Lee HY; Wang Y; Chen IA; Castellani D; Wroclawski ML; Mayor N; Sathianathen NJ; Braga I; Liu Z; Moon D; Tikkinen K; Kamat A; Meng M; Ficarra V; Giannarini G; Teoh JY
World J Urol; 2021 Dec; 39(12):4295-4303. PubMed ID: 34031748
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis.
Jiang YL; Peng CX; Wang HZ; Qian LJ
BMC Urol; 2019 Jun; 19(1):48. PubMed ID: 31174522
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
12. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of the Controlling Nutritional Status score on patients undergoing nephrectomy for upper tract urothelial carcinoma or renal cell carcinoma: a systematic review and meta-analysis.
Chen J; Cao D; Peng Z; Song P; Liu Z; Yang L; Wang L; Zhou J; Wei Q; Dong Q
Br J Nutr; 2022 Jul; 128(2):217-224. PubMed ID: 34338171
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
Xue W; Zhang Y; Wang H; Zhang Y; Hu X
Front Immunol; 2021; 12():778746. PubMed ID: 34917092
[TBL] [Abstract][Full Text] [Related]
15. The effect of perioperative blood transfusion on survival after renal cell carcinoma nephrectomy: A systematic review and meta-analysis.
Liu Y; Deng X; Wen Z; Huang J; Wang C; Chen C; Yang X
Front Oncol; 2023; 13():1092734. PubMed ID: 36874080
[TBL] [Abstract][Full Text] [Related]
16. Statin use and kidney cancer outcomes: A propensity score analysis.
Nayan M; Finelli A; Jewett MAS; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
Urol Oncol; 2016 Nov; 34(11):487.e1-487.e6. PubMed ID: 27427224
[TBL] [Abstract][Full Text] [Related]
17. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
18. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
19. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
20. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
Kim SI; Kim SJ; Kim SJ; Cho DS
Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
